Perfil
Thomas V. Hennessey forma parte del consejo de administración de AutoGenomics, Inc. En el pasado fue Director de Operaciones y Finanzas de AutoImmune, Inc., Director de Operaciones y Finanzas de Boston Scientific Corp., Director de Operaciones y Finanzas de Cambridge Heart, Inc., Director de Finanzas de LumeRx, Inc., Director de Operaciones y Finanzas de Photovac, Inc., Director de Operaciones y Finanzas de Behring Diagnostics Business, Director de Operaciones y Finanzas de PHT Corp., Director de Operaciones y Finanzas de Medical Diagnostics, Inc. y Director de Operaciones y Finanzas de SonaMed Corp. Thomas V. Hennessey se licenció y se graduó en el Massachusetts Institute of Technology y obtuvo un MBA en la Harvard Business School.
Cargos activos de Thomas Hennessey
| Empresas | Cargo | Inicio |
|---|---|---|
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Thomas Hennessey.
| Empresas | Cargo | Fin |
|---|---|---|
Photovac, Inc.
Photovac, Inc. Medical SpecialtiesHealth Technology Portable environmental instruments | Director Financiero/CFO | 01/01/2003 |
PHT Corp.
PHT Corp. Packaged SoftwareTechnology Services Designs and develops software applications | Director Financiero/CFO | - |
| CAMBRIDGE HEART, INC. | Director Financiero/CFO | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology Designs and develops molecular diagnostics system | Director Financiero/CFO | 31/08/2013 |
SonaMed Corp.
SonaMed Corp. Medical SpecialtiesHealth Technology Designs and develops medical devices | Director Financiero/CFO | - |
Formación de Thomas Hennessey.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 13 |
|---|---|
AutoImmune, Inc.
AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Health Technology |
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Cambridge Heart, Inc.
Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Engages in research, development and commercialization of products for the non-invasive diagnosis of cardiac disease | Health Technology |
LumeRx, Inc.
LumeRx, Inc. Medical SpecialtiesHealth Technology Develops radiation technology that eliminates bacteria | Health Technology |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology Designs and develops molecular diagnostics system | Health Technology |
Medical Diagnostics, Inc.
Medical Diagnostics, Inc. Medical/Nursing ServicesHealth Services Mobile MRI services | Health Services |
PHT Corp.
PHT Corp. Packaged SoftwareTechnology Services Designs and develops software applications | Technology Services |
Behring Diagnostics Business
Behring Diagnostics Business Medical SpecialtiesHealth Technology Provides diagnostic services | Health Technology |
Photovac, Inc.
Photovac, Inc. Medical SpecialtiesHealth Technology Portable environmental instruments | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
SonaMed Corp.
SonaMed Corp. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Hennessey
















